Strongyloides stercoralis Infestation Manifesting as Protein Losing Enteropathy and Dyselectrolytaemia in an Immunocompetent Adult: A Case Report.

Autor: JAJODIA, AMIT¹, PANIGRAHY, GYANAMITRA², MOHANTY, NIHAR RANJAN² drnihar123@yahoo.com, MOHANTY, LALATENDU³, SINGH, NIPA⁴

Publikováno v: Journal of Clinical & Diagnostic Research. Feb2024, Vol. 18 Issue 2, p1-4. 4p.

The Rising Incidence and Poor Outcomes of Enteropathy-Associated T-Cell Lymphoma.

Autor: Hujoel IA; Division of Gastroenterology, University of Washington, Seattle, Washington, USA., Hujoel MLA; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Publikováno v: The American journal of gastroenterology [Am J Gastroenterol] 2024 Jul 01; Vol. 119 (7), pp. 1412-1416. Date of Electronic Publication: 2024 Jan 18.

Protein-losing enteropathy with congenital kidney stones in a 2-month-old boy: a rare case report and literature review.

Autor: Fang, Jiahui¹ (AUTHOR), Li, Zhuoheng¹ (AUTHOR), Zhang, Lin² (AUTHOR), Liu, Qiaojian³ (AUTHOR), Mao, Jie⁴ (AUTHOR), Duan, Jintao¹ (AUTHOR) djt202307@163.com

Publikováno v: BMC Medical Genomics. 11/27/2024, Vol. 17 Issue 1, p1-5. 5p.

Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy

Autor: Hyun Jung Lee, Ji Wook Moon, Seong-Joon Koh, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim

Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)

Abstract As the non-steroidal anti-inflammatory drugs (NSAIDs) are typically used in the treatment of chronic conditions, the incidence of NSAID-induced enteropathy is increasing. Given the challenges associated with discontinuing NSAIDs, effective p

Externí odkaz: https://doaj.org/article/b731d63aa2014725b0b864bf640f7e78

A wolf in sheep's clothing: enteropathy associated T-cell lymphoma involving a nasal polyp masquerading as primary mucosal CD30-positive T-cell lymphoproliferative disorder.

Autor: Attygalle AD; Department of Histopathology, The Royal Marsden Hospital, London, UK., Vroobel KM; Department of Histopathology, The Royal Marsden Hospital, London, UK., Madej E; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK., Tzioni MM; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK., Zhang C; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK., Chen Z; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK., Ribeiro S; Department of Clinical Genomics, Royal Marsden Hospital, Sutton, UK., Calvachini S; Department of Cytogenetics, Royal Marsden Hospital, Sutton, UK., Sharma B; Department of Radiology, The Royal Marsden Hospital, Institute of Cancer Research, London, UK., Alexander EJ; Department of Clinical Oncology, Royal Marsden, London, UK., Wotherspoon AC; Department of Histopathology, The Royal Marsden Hospital, London, UK., Du MQ; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK.

Publikováno v: Histopathology [Histopathology] 2024 Jun; Vol. 84 (7), pp. 1238-1241. Date of Electronic Publication: 2024 Feb 21.